SCHEMBL21363793

SCHEMBL21363793

C=CCc1cc2c(cc1OC(C)c1ccccc1)OCO2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.41
CYP1A2 P05177 2/20 0.41
MAPT P10636 1/20 0.41
ADRA2A P08913 4/20 0.41
ADRA2B P18089 4/20 0.41
ADRA2C P18825 4/20 0.41
HTR1A P08908 2/20 0.41
KCNH2 Q12809 1/20 0.41
POLB P06746 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 1/20 0.39
ALOX15 P16050 1/20 0.37
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
PREP P48147 1/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 1/20 0.36
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14552348 0.75 MAOB (0.54) CYP3A4CYP1A2MAPTHTR1APOLB
SCHEMBL14552371 0.74 POLB (0.61) CYP3A4CYP1A2MAPTPOLBSMN1; SMN2
SCHEMBL21363678 0.73 CDK4 (0.45) CYP3A4CYP1A2MAPTADRA2AADRA2B
SCHEMBL7988383 0.72 LTB4R (0.53) POLBMEN1KMT2AALDH1A1TSHR
SCHEMBL21363605 0.71 POLB (0.48) CYP3A4CYP1A2MAPTPOLBMEN1
SCHEMBL21363751 0.69 CYP1A2 (0.41) CYP3A4CYP1A2MAPTPOLBMEN1
SCHEMBL21363746 0.69 USP2 (0.44) CYP3A4CYP1A2MAPTADRA2AADRA2B
SCHEMBL21363612 0.69 HPGD (0.44) CYP3A4CYP1A2MAPTADRA2AADRA2B
SCHEMBL4843039 0.69 POLB (0.48) CYP3A4CYP1A2MAPTPOLBSMN1; SMN2
SCHEMBL7990417 0.68 LTB4R (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019175713-A1 NEW CATECHOL MOLECULES AND THEIR USE AS INHIBITORS TO P450 RELATED METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed
WO-2019175712-A1 NEW USES FOR CATECHOL MOLECULES AS INHIBITORS TO GLUTATHIONE S-TRANSFERASE METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed